Want to see KR:007460 full AI Analyst Report?
Aprogen, Inc (007460) Financial Statements
Aprogen, Inc Financial Overview
Aprogen, Inc's market cap is currently $9.15B. The company's EPS TTM is $-31115.21; its P/E ratio is -0.06; Aprogen, Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 117.97B | $ 150.11B | $ 150.58B | $ 78.35B | $ 141.25B |
| Gross Profit | $ 33.24B | $ 34.90B | $ 35.81B | $ 6.15B | $ 31.25B |
| Operating Income | $ -141.47B | $ -86.81B | $ -88.87B | $ -114.35B | $ -2.67B |
| EBITDA | $ -113.95B | $ -73.38B | $ -65.54B | $ -76.10B | $ -72.32B |
| Net Income | $ -69.48B | $ -58.08B | $ -55.62B | $ -116.08B | $ -12.50B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 50.15B | $ 43.66B | $ 40.68B | $ 47.46B | $ 159.81B |
| Total Assets | $ 718.99B | $ 609.97B | $ 594.43B | $ 599.85B | $ 824.11B |
| Total Debt | $ 187.86B | $ 113.70B | $ 124.42B | $ 90.20B | $ 78.98B |
| Net Debt | $ 142.71B | $ 76.54B | $ 88.73B | $ 47.13B | $ 16.60B |
| Total Liabilities | $ 256.56B | $ 169.88B | $ 176.74B | $ 138.85B | $ 119.75B |
| Stockholders' Equity | $ 156.71B | $ 158.63B | $ 147.80B | $ 215.09B | $ 335.95B |
| Cash Flow | |||||
| Free Cash Flow | $ -42.75B | $ -68.14B | $ -113.04B | $ -138.31B | $ -10.72B |
| Operating Cash Flow | $ -33.76B | $ -44.99B | $ -58.16B | $ -113.49B | $ -8.61B |
| Investing Cash Flow | $ -62.74B | $ -40.50B | $ -43.45B | $ 70.17B | $ -32.46B |
| Financing Cash Flow | $ 102.98B | $ 86.62B | $ 94.30B | $ 70.80B | $ 6.61B |
Currency in KRW